- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06230848
Multisensory Early Oral Administration of Human Milk in Preterm Infants (M-MILK)
December 17, 2025 updated by: Thao Griffith, Loyola University
Multisensory Early Oral Administration of Human Milk in Preterm Infants to Attenuate Early Life Toxic Stress on Epigenetic Modifications and Dysbiosis: Randomized Controlled Trial Pilot Study
The aims of this pilot are to determine the feasibility and acceptability of the Multisensory early oral administration of human milk (M-MILK) intervention, recruitment, retention, and obtain data for sample size estimation.
This study will advance nursing science and practice because it will inform our R01 RCT to examine the efficacy of M-MILK to attenuate adverse effects of early life toxic stress in preterm infants.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
14
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Maywood, Illinois, United States, 60153
- Loyola University Chicago
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- born between 22 to 34 weeks gestational age and receiving mother's own milk and/or donor milk.
Exclusion Criteria:
- receiving only formula, oral cavity defects, gastrointestinal defects, chromosomal abnormalities, severe cardiac defects that require surgery, or intraventricular hemorrhage grade III or IV
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: M-MILK
Infants in the M-MILK group will receive the M-MILK intervention in addition to standard of care.
|
M-MILK is implemented starting on day 3 of life, after every hands-on care, during the beginning of a full gavage feeding.
Infants receive M-MILK in small droplets via a 1-ml syringe.
M-MILK will cease upon oral feeding initiation.
Infants will receive either mother's own milk or donor's milk based on availability.
Infants may receive up to 1 mL of milk each time based on their cues and responses.
The 1 mL volume intake is included as part of their oral caloric intake.
M-MILK is provided by nurses or parents.
|
|
No Intervention: Control
Infants in the control group will receive standard of care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of Intervention
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The count of participants who receive M-MILK in at least 50% of their scheduled M-MILK administrations.
MILK will be considered feasible if M-MILK is implemented by nurses or parents after every hands-on care and during the beginning of a full gavage feeding at least 50% of the time.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
|
Acceptability of Intervention
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The percentage of parents who rate the intervention as very positive, slightly positive, or acceptable on a 5-point Likert scale.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
|
Retention
Time Frame: 2 months corrected age
|
Retention will be described by the number of post-discharge follow-up surveys completed.
|
2 months corrected age
|
|
The Scarf Sign Cluster of the Neurobehavioral Assessment of the Preterm Infants Score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The Neurobehavioral Assessment of the Preterm Infants (NAPI, 73 items, 32-37 weeks PMA): cluster score for scarf sign ranges from 0-100, where higher scores indicate better neurodevelopmental performance.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
|
Variability in the Motor Development & Vigor Cluster of the Neurobehavioral Assessment of the Preterm Infants Score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The Neurobehavioral Assessment of the Preterm Infants (NAPI, 73 items, 32-37 weeks PMA): cluster score for motor development & vigor ranges from 0-100, where higher scores indicate better neurodevelopmental performance.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
|
Popliteal Angle Cluster of the Neurobehavioral Assessment of the Preterm Infants Score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The Neurobehavioral Assessment of the Preterm Infants (NAPI, 73 items, 32-37 weeks PMA): cluster score for popliteal angle ranges from 0-100, where higher scores indicate better neurodevelopmental performance.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
|
Alertness and Orientation Cluster of the Neurobehavioral Assessment of the Preterm Infants Score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The Neurobehavioral Assessment of the Preterm Infants (NAPI, 73 items, 32-37 weeks PMA): cluster score for alertness and orientation ranges from 0-100, where higher scores indicate better neurodevelopmental performance.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
|
Irritability Cluster of the Neurobehavioral Assessment of the Preterm Infants Score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The Neurobehavioral Assessment of the Preterm Infants (NAPI, 73 items, 32-37 weeks PMA): cluster score for irritability ranges from 0-100, where higher scores indicate better neurodevelopmental performance.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
|
Quality of Cry Cluster of the Neurobehavioral Assessment of the Preterm Infants Score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The Neurobehavioral Assessment of the Preterm Infants (NAPI, 73 items, 32-37 weeks PMA): cluster score for quality of cry ranges from 0-100, where higher scores indicate better neurodevelopmental performance.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
|
Percent Sleep Cluster of the Neurobehavioral Assessment of the Preterm Infants Score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The Neurobehavioral Assessment of the Preterm Infants (NAPI, 73 items, 32-37 weeks PMA): cluster score for percent sleep ranges from 0-100, where higher scores indicate better neurodevelopmental performance.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
|
Early Feeding Skill Assessment Score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
EFS has 22 items (32-50 weeks PMA), summary scores, 5 subscales: respiratory regulation (range 5 - 15), oral-motor functioning (range 4 - 12), swallowing coordination (range 4 - 12), engagement (range 2 - 6), & physiologic stability (range 4 - 12), where higher scores indicate better oral feeding skill development.
The total score is the sum of the subscales and ranges from 19-57.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Parent Stressor Scale: NICU Score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Scores range from 1 to 5, where higher scores indicate greater parental stress..
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
|
Parent Discharge Readiness Score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Scores range from 44 to 308, where higher scores indicate more parental readiness for discharge.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
|
Breastmilk Pumping Rate
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The percentage of mothers who report breastmilk pumping at discharge.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
|
Breastfeeding Rate
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The percentage of mothers who report breastfeeding at discharge.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
|
Maternal Edinburgh Postnatal Depression Scale Score
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Scores range from 0 to 30, where higher scores indicate greater depressive symptoms
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Variability in Gut Microbial Community Structure and Relative Abundance of SCFA- and Lactate- Producing Bacteria
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Alpha diversity indices will be obtained.
Differential abundance individual taxa will be obtained.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
|
Variability in DNA Methylation of NR3C1 Promoter
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The percent DNAm at the NR3C1 promoters and at each CpG site will be quantified.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
|
Variability in DNA Methylation of HSD11B2 Promoter
Time Frame: At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
The percent DNAm at the HSD11B2 promoters and at each CpG site will be quantified.
|
At the time of discharge from NICU, which is typically 10 to 16 weeks from birth.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 23, 2023
Primary Completion (Actual)
October 23, 2024
Study Completion (Actual)
October 23, 2024
Study Registration Dates
First Submitted
January 5, 2024
First Submitted That Met QC Criteria
January 25, 2024
First Posted (Actual)
January 30, 2024
Study Record Updates
Last Update Posted (Actual)
January 8, 2026
Last Update Submitted That Met QC Criteria
December 17, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 217411
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
Center for Advanced Facial Plastic SurgeryCompletedStress | Stress, Physiological | Stress Response | Stress (Psychology) | Healthy Adult Female Participants | Stress, Psychologic | Stress Perception | Stress Levels | Stress, Psychological CumulativeUnited States
-
Amsterdam UMC, location VUmcRigshospitalet, Denmark; Universitätsklinikum Hamburg-EppendorfNot yet recruitingStress | Stress and Burnout | Stress BiomarkersGermany, Denmark
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...CompletedStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
Amasya UniversityCompletedThe Effect of Online Stress Management Program on Nurses' Individual Workload Perception, and StressStress | Nursing | Stress ManagementTurkey (Türkiye)
-
Canterbury Christ Church UniversitySussex Partnership NHS Foundation TrustEnrolling by invitationOccupational Stress or Workplace StressUnited Kingdom
-
University of PadovaCompletedStress | Stress Disorder | Work Related StressItaly
-
University of Thi-QarCompletedPsychological Stress | Academic StressIraq
-
K.G. Razumovsky Moscow State University of Technologies...RecruitingStress | Stress (Psychology)Russia
-
University of Auckland, New ZealandNot yet recruiting
Clinical Trials on Multisensory Early Oral Administration of Human Milk (M-MILK)
-
Loyola UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingInfant, Premature, DiseasesUnited States
-
University of California, DavisUniversity of California, Los Angeles; National Center for Advancing Translational... and other collaboratorsRecruiting
-
Children's Hospital and Institute of Child Health...Not yet recruiting
-
The University of Texas Health Science Center at...CompletedNeonatal Abstinence SyndromeUnited States
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...CompletedPostnatal Growth Failure of Preterm Infants | Human Milk Fortification
-
University of FloridaNational Institute of Nursing Research (NINR)CompletedBreast Milk ExpressionUnited States
-
a2 Milk Company Ltd.Completed
-
Mansoura University Children HospitalCompletedPreterm Infant | Feeding Disorder Neonatal | Gastrointestinal Motility DisorderEgypt
-
Mansoura University Children HospitalCompletedPreterm Infant | Neonatal SEPSIS | Neonatal Feeding DisorderEgypt
-
a2 Milk Company Ltd.CompletedLactose Intolerance